Immix Biopharma
IMMX
#7157
Rank
NZ$1.06 B
Marketcap
NZ$12.72
Share price
-1.14%
Change (1 day)
64.99%
Change (1 year)

Earnings for Immix Biopharma (IMMX)

Earnings in 2026 (TTM): -NZ$72.75 Million

According to Immix Biopharma's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$54.77 Million a decrease over its 2024 earnings that were of -NZ$41.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immix Biopharma from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$72.75 Million32.85%
2025 -NZ$54.77 Million32.11%
2024 -NZ$41.45 Million42.5%
2023 -NZ$29.09 Million93.61%
2022 -NZ$15.03 Million-66.03%
2021 -NZ$44.24 Million